EyeGate Pharmaceuticals, Inc.
(NASDAQ : EYEG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.21%181.230.4%$209.85m
AMRNAmarin Corporation Plc Sponsored ADR
1.53%15.622.0%$197.15m
PRGOPerrigo Co. Plc
-2.89%63.506.8%$106.62m
JAZZJazz Pharmaceuticals Plc
-5.37%142.602.2%$102.70m
ENDPEndo International Plc
-4.14%12.968.9%$66.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-3.14%128.036.3%$63.32m
MNKMallinckrodt Plc
0.56%31.2521.1%$56.07m
SAGESAGE Therapeutics, Inc.
-1.98%106.889.6%$51.75m
ICPTIntercept Pharmaceuticals, Inc.
-5.26%95.4118.7%$46.75m
HZNPHorizon Pharma plc
-2.01%21.417.4%$45.54m
UTHRUnited Therapeutics Corporation
-1.35%111.2014.4%$43.10m
CTLTCatalent Inc
-0.96%37.862.4%$36.15m
PTLAPortola Pharmaceuticals, Inc.
-3.64%19.357.7%$34.58m
ICLRICON Plc
-0.88%136.774.1%$34.25m
AERIAerie Pharmaceuticals, Inc.
-6.11%40.686.9%$26.90m

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.